Healthcare provider profile · identity verified

Robert Schwartz, MD

Family Practice · MANCHESTER CENTER, VT · NPI 1851316277

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	640	180
Lisinopril	Lisinopril	367	107
Amlodipine Besylate	Amlodipine Besylate	267	81
Levothyroxine Sodium	Levothyroxine Sodium	227	62
Omeprazole	Omeprazole	221	61
Sertraline Hcl	Sertraline Hcl	189	47
Gabapentin	Gabapentin	167	48
Losartan Potassium	Losartan Potassium	165	45
Metoprolol Succinate	Metoprolol Succinate	158	49
Metformin Hcl	Metformin Hcl	146	34
Eliquis	Apixaban	139	38
Pantoprazole Sodium	Pantoprazole Sodium	138	36
Tamsulosin Hcl	Tamsulosin Hcl	119	31
Trazodone Hcl	Trazodone Hcl	119	42
Hydrochlorothiazide	Hydrochlorothiazide	105	34
Albuterol Sulfate Hfa	Albuterol Sulfate	103	47
Famotidine	Famotidine	101	31
Simvastatin	Simvastatin	95	26
Prednisone	Prednisone	85	50
Allopurinol	Allopurinol	81	27
Fluticasone Propionate	Fluticasone Propionate	81	34
Metoprolol Tartrate	Metoprolol Tartrate	76	22
Rosuvastatin Calcium	Rosuvastatin Calcium	76	26
Duloxetine Hcl	Duloxetine Hcl	73	21
Lorazepam	Lorazepam	72	33
Finasteride	Finasteride	70	15
Tramadol Hcl	Tramadol Hcl	68	suppressed
Potassium Chloride	Potassium Chloride	66	25
Clopidogrel	Clopidogrel Bisulfate	65	15
Doxycycline Hyclate	Doxycycline Hyclate	65	52
Furosemide	Furosemide	63	22
Escitalopram Oxalate	Escitalopram Oxalate	60	20
Mirtazapine	Mirtazapine	60	16
Candesartan Cilexetil	Candesartan Cilexetil	58	15
Oxycodone Hcl	Oxycodone Hcl	58	11
Warfarin Sodium	Warfarin Sodium	58	suppressed
Chlorthalidone	Chlorthalidone	57	19
Jardiance	Empagliflozin	55	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	17
Torsemide	Torsemide	52	20
Ozempic	Semaglutide	51	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	suppressed
Pregabalin	Pregabalin	48	18
Quetiapine Fumarate	Quetiapine Fumarate	45	11
Amitriptyline Hcl	Amitriptyline Hcl	44	13
Atenolol	Atenolol	44	12
Fluoxetine Hcl	Fluoxetine Hcl	42	12
Tizanidine Hcl	Tizanidine Hcl	42	13
Triamcinolone Acetonide	Triamcinolone Acetonide	42	27
Bupropion Xl	Bupropion Hcl	41	12
Carvedilol	Carvedilol	40	suppressed
Glimepiride	Glimepiride	39	suppressed
Clonazepam	Clonazepam	38	suppressed
Trulicity	Dulaglutide	38	suppressed
Baclofen	Baclofen	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	16
Metformin Hcl Er	Metformin Hcl	33	suppressed
Cephalexin	Cephalexin	31	21
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Topiramate	Topiramate	22	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Clotrimazole	Clotrimazole	20	14
Donepezil Hcl	Donepezil Hcl	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Glipizide	Glipizide	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Diazepam	Diazepam	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Spironolactone	Spironolactone	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Zolmitriptan	Zolmitriptan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error